Surrozen (SRZN) Enterprise Value (2020 - 2026)
Surrozen (SRZN) recorded quarterly Enterprise Value of -$106.9 million in Q1 2026, down 19.79% quarter-over-quarter from -$89.2 million in Q4 2025, and down 5.18% on a YoY basis from -$112.8 million in Q1 2025.
Surrozen (SRZN) Enterprise Value (2020 - 2026) Analysis & Trends
Surrozen's Enterprise Value history runs 7 years deep, the most recent figure standing at -$106.9 million for Q1 2026.
- In Q1 2026, Enterprise Value fell 5.18% year-over-year to -$106.9 million; the TTM figure through Mar 2026 stood at -$106.9 million (down 5.18% YoY), while the FY2025 annual figure was -$89.2 million, down 158.19% from the prior year.
- Enterprise Value was -$106.9 million for Q1 2026 at Surrozen, down from -$89.2 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$27.3 million in Q1 2024 to a low of -$106.9 million in Q1 2026.
- Historically, Enterprise Value has averaged -$66.7 million across 5 years, with a median of -$75.8 million in 2022.
- The sharpest annual moves came in 2022 and 2024: Enterprise Value plunged 391.72% in 2022, then surged 55.8% in 2024.
- A 5-year view of Enterprise Value shows it stood at -$75.8 million in 2022, then soared by 52.47% to -$36.0 million in 2023, then increased by 4.1% to -$34.6 million in 2024, then tumbled by 158.19% to -$89.2 million in 2025, then slipped by 19.79% to -$106.9 million in 2026.
- The last three Enterprise Value figures came in at -$106.9 million (Q1 2026), -$89.2 million (Q4 2025), and -$81.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -2.77 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -18.44 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -584.73 Mn |
| 10 | Surrozen | 225,877.86 | -106.68 Mn | - | -106.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -106.91 Mn |
| Dec 31, 2025 | -89.25 Mn |
| Sep 30, 2025 | -81.30 Mn |
| Jun 30, 2025 | -90.40 Mn |
| Mar 31, 2025 | -101.65 Mn |
| Dec 31, 2024 | -34.57 Mn |
| Sep 30, 2024 | -31.01 Mn |
| Jun 30, 2024 | -37.77 Mn |
| Mar 31, 2024 | -27.29 Mn |
| Dec 31, 2023 | -36.04 Mn |
| Sep 30, 2023 | -43.43 Mn |
| Jun 30, 2023 | -53.40 Mn |
| Mar 31, 2023 | -61.75 Mn |
| Dec 31, 2022 | -75.84 Mn |
| Sep 30, 2022 | -78.40 Mn |
| Jun 30, 2022 | -92.69 Mn |
| Mar 31, 2022 | -92.51 Mn |
| Dec 31, 2021 | -101.85 Mn |
| Sep 30, 2021 | -110.17 Mn |
| Jun 30, 2021 | -18.85 Mn |